Double maintains 3 strategies that include BEAM - Beam Therapeutics, Inc.
Yahoo
Presentation to Include Updated Data from 17 Sickle Cell Disease Patients in the Ongoing BEACON Phase 1/2 Clinical Trial Evaluating Safety and Efficacy of BEAM-101 Beam to Host Investor Webcast on Friday, June 13, 2025, at 4:00 p.m. ET CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present new data from the BEACON Phase 1/2 clinical
Yahoo
CAMBRIDGE, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that management will participate in a fireside chat at the 2025 RBC Capital Markets Global Healthcare Conference on Tuesday, May 20, 2025, at 11:00 a.m. ET in New York. The live webcast will be available in the investor section of the company's website at www.beamtx.com and will be archived for 60 days follo
Yahoo
CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to BEAM-302, a liver-targeting lipid-nanoparticle (LNP) formulation of a guide RNA and an mRNA encoding a base editor designed to correct the disease-causing mutation in pati
Yahoo
Novavax posts encouraging first-quarter results on the back of an additional $603 million in revenues recognized from the termination of two advanced purchase agreements.
Yahoo
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
SeekingAlpha
Read here for ARK Invest's latest 13F updates: portfolio value shifts, top holdings, significant trades, and their open-source investment research approach.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -47.03% | $361.71M | 1.43% |
VIXY | -44.74% | $116.60M | 0.85% |
TAIL | -41.66% | $140.64M | 0.59% |
IVOL | -25.28% | $353.50M | 1.02% |
FTSD | -17.57% | $212.61M | 0.25% |
SPTS | -16.86% | $5.74B | 0.03% |
SCHO | -16.40% | $10.84B | 0.03% |
UTWO | -15.35% | $384.77M | 0.15% |
FXY | -15.21% | $850.17M | 0.4% |
XONE | -15.17% | $608.48M | 0.03% |
VGSH | -15.03% | $22.36B | 0.03% |
ULST | -14.63% | $632.05M | 0.2% |
LDUR | -13.28% | $850.25M | 0.5% |
IBTH | -12.17% | $1.53B | 0.07% |
SHYM | -12.11% | $323.00M | 0.35% |
IBTG | -11.82% | $1.89B | 0.07% |
CGSM | -11.70% | $663.73M | 0.25% |
STPZ | -11.51% | $452.72M | 0.2% |
FTSM | -11.31% | $6.51B | 0.45% |
BSMW | -10.92% | $102.64M | 0.18% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 77.18% | $39.83M | 0.5% |
ARKG | 77.01% | $914.43M | 0.75% |
XBI | 69.84% | $4.85B | 0.35% |
IBB | 64.31% | $5.17B | 0.45% |
PBE | 63.86% | $215.67M | 0.58% |
IWC | 63.77% | $772.99M | 0.6% |
ARKK | 62.21% | $5.72B | 0.75% |
IWM | 61.39% | $63.66B | 0.19% |
VTWO | 61.36% | $12.07B | 0.07% |
IWO | 61.18% | $11.31B | 0.24% |
KJAN | 60.57% | $304.58M | 0.79% |
SCHA | 59.74% | $16.85B | 0.04% |
IWN | 59.67% | $11.00B | 0.24% |
GSSC | 59.28% | $536.87M | 0.2% |
KJUL | 58.98% | $113.06M | 0.79% |
NUSC | 58.90% | $1.14B | 0.31% |
PRFZ | 58.89% | $2.33B | 0.34% |
FYX | 58.77% | $811.05M | 0.6% |
CPRJ | 58.68% | $48.36M | 0.69% |
ESML | 58.57% | $1.80B | 0.17% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CRSP | 71.16% | $3.34B | -30.27% | 0.00% |
NTLA | 66.67% | $938.46M | -65.01% | 0.00% |
RXRX | 62.91% | $1.83B | -53.89% | 0.00% |
DNLI | 60.93% | $2.02B | -30.90% | 0.00% |
ABCL | 58.06% | $602.94M | -45.99% | 0.00% |
SYRE | 57.62% | $898.06M | -59.64% | 0.00% |
EYPT | 56.08% | $419.75M | -49.75% | 0.00% |
TXG | 55.90% | $1.11B | -64.04% | 0.00% |
RCKT | 55.85% | $694.91M | -71.75% | 0.00% |
BLFS | 55.37% | $1.09B | +5.08% | 0.00% |
IMNM | 55.16% | $696.97M | -41.96% | 0.00% |
XNCR | 55.13% | $573.64M | -66.06% | 0.00% |
ARWR | 54.56% | $2.17B | -36.58% | 0.00% |
KYMR | 54.50% | $1.97B | -16.13% | 0.00% |
TWST | 53.92% | $1.82B | -32.27% | 0.00% |
CLDX | 53.67% | $1.39B | -44.61% | 0.00% |
ACLX | 53.47% | $3.22B | +7.63% | 0.00% |
RGNX | 53.06% | $491.07M | -38.31% | 0.00% |
IDYA | 52.90% | $1.58B | -55.16% | 0.00% |
LFUS | 52.21% | $5.35B | -17.72% | 1.28% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IAGG | -0.09% | $7.31B | 0.07% |
CGCB | 0.10% | $2.21B | 0.27% |
NUBD | 0.10% | $389.20M | 0.16% |
SPTL | 0.11% | $11.03B | 0.03% |
IBMR | 0.13% | $237.75M | 0.18% |
VGLT | 0.15% | $9.57B | 0.04% |
TDTF | 0.16% | $792.63M | 0.18% |
PULS | 0.25% | $11.19B | 0.15% |
FIXD | -0.27% | $3.55B | 0.65% |
VCRB | -0.31% | $2.84B | 0.1% |
TLH | 0.34% | $9.88B | 0.15% |
SHV | -0.35% | $20.91B | 0.15% |
SCHQ | 0.36% | $835.09M | 0.03% |
GOVZ | -0.38% | $254.19M | 0.1% |
EUSB | 0.39% | $685.00M | 0.12% |
IBTF | -0.44% | $2.11B | 0.07% |
USTB | 0.50% | $1.20B | 0.35% |
TOTL | 0.59% | $3.60B | 0.55% |
CGMU | -0.63% | $3.12B | 0.27% |
BIV | 0.65% | $22.90B | 0.03% |
Current Value
$17.621 Year Return
Current Value
$17.621 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -29.29% | $23.50B | +22.83% | 1.09% |
CME | -14.57% | $100.16B | +31.56% | 3.79% |
ED | -14.34% | $37.97B | +9.19% | 3.17% |
T | -11.73% | $201.62B | +59.93% | 3.95% |
EXC | -11.54% | $44.81B | +15.42% | 3.50% |
DUK | -10.84% | $90.93B | +12.86% | 3.55% |
K | -10.21% | $28.59B | +32.73% | 2.75% |
VHC | -10.15% | $35.49M | +75.53% | 0.00% |
LITB | -9.65% | $22.07M | -71.93% | 0.00% |
MO | -9.61% | $100.17B | +29.56% | 6.73% |
KMB | -9.17% | $46.72B | +5.37% | 3.49% |
AQB | -8.39% | $3.17M | -56.89% | 0.00% |
VSA | -7.91% | $6.80M | -46.67% | 0.00% |
AMT | -7.81% | $100.71B | +12.19% | 3.05% |
AWK | -7.55% | $28.03B | +7.59% | 2.17% |
FMTO | -7.53% | $46.19M | -99.95% | 0.00% |
VZ | -5.70% | $186.82B | +10.44% | 6.07% |
AEP | -5.54% | $55.44B | +12.09% | 3.53% |
AIFU | -5.49% | $10.03M | -94.68% | 0.00% |
DRD | -5.25% | $1.25B | +54.36% | 1.87% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HEES | -0.03% | $3.52B | +97.88% | 1.15% |
MNOV | -0.12% | $68.66M | +2.19% | 0.00% |
PHYS | -0.13% | - | - | 0.00% |
MKTX | 0.17% | $8.23B | +1.72% | 1.35% |
CHD | -0.19% | $23.64B | -9.90% | 1.20% |
AU | 0.30% | $21.24B | +63.11% | 2.12% |
KO | 0.32% | $309.61B | +14.96% | 2.73% |
AGI | 0.34% | $10.55B | +45.73% | 0.39% |
MDLZ | 0.42% | $85.10B | -6.47% | 2.78% |
CORT | 0.52% | $7.93B | +159.07% | 0.00% |
CB | 0.56% | $118.05B | +11.52% | 1.24% |
CCI | -0.67% | $44.84B | +2.35% | 6.08% |
OHI | -0.70% | $10.83B | +21.26% | 7.14% |
NEUE | 0.70% | $61.07M | +15.93% | 0.00% |
ZCMD | -0.80% | $32.33M | -15.23% | 0.00% |
ALL | 0.90% | $55.60B | +25.07% | 1.79% |
DG | 0.97% | $21.59B | -28.77% | 2.34% |
NOC | 0.97% | $67.81B | +0.46% | 1.75% |
ASPS | -1.05% | $75.24M | -50.06% | 0.00% |
FE | 1.09% | $24.73B | +6.96% | 4.00% |